InvestorsHub Logo
Followers 43
Posts 4308
Boards Moderated 0
Alias Born 09/01/2017

Re: Johnni post# 334167

Sunday, 11/29/2020 10:59:39 PM

Sunday, November 29, 2020 10:59:39 PM

Post# of 702102
What I remember is that the mesynchimal (sp?) subtype of GBM seems to do better with dcvax despite being the relatively worse prognosis. I think the more mixed the tumor is, the more targets for the dcvax enhanced immune response. The methylation and IHG types also factor in, if memory serves me.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News